Group Kuiper

Medicijnen en Levenswetenschappen

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
2. Pediatrics 61%
3. Neoplasms 48%
4. Wilms Tumor 44%
5. B-Lymphoid Precursor Cells 42%
6. Mutation 34%
7. Recurrence 27%
8. Child 23%
9. Leukemia 21%
10. Germ-Line Mutation 20%
11. Clonal Evolution 19%
12. Turcot syndrome 19%
13. Residual Neoplasm 18%
14. Genes 18%
15. Colorectal Neoplasms 15%
16. Kidney 13%
17. High-Throughput Nucleotide Sequencing 13%
18. Netherlands 12%
19. DNA Repair 12%
20. Phenotype 12%
21. WAGR Syndrome 11%
22. Molecular Probes 11%
23. Adenoma 11%
24. Hepatoblastoma 11%
25. Hereditary leiomyomatosis and renal cell cancer 11%
26. Glucocorticoid Receptor Deficiency 10%
27. Haploinsufficiency 10%
28. Vulvar Lichen Sclerosus 10%
29. Typical Teratoid Rhabdoid Tumor 9%
30. Atypical Teratoid Tumor 9%
31. Fumarate Hydratase 9%
32. Interleukin-7 Receptors 9%
33. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9%
34. Cancer Survivors 9%
35. TYK2 Kinase 9%
36. Agammaglobulinaemia Tyrosine Kinase 9%
37. Hereditary Nonpolyposis Colorectal Neoplasms 9%
38. Asparaginase 8%
39. Gene Deletion 8%
40. Spliceosomes 8%
41. Polyps 8%
42. Genetic Testing 8%
43. Retroelements 8%
44. Exome 8%
45. B-Lymphocytes 7%
46. Ribosomal Proteins 7%
47. Neoplasm Genes 7%
48. Chromosome Mapping 7%
49. Survivors 7%
50. Therapeutics 7%
51. Lichen Sclerosus et Atrophicus 7%
52. Gastrointestinal Neoplasms 7%
53. T-Cell Lymphoma 7%
54. Gene Fusion 7%
55. Lymphoma, Large B-Cell, Diffuse 7%
56. Genomic Instability 6%
57. Immunoglobulins 6%
58. Incidence 6%
59. Early Detection of Cancer 6%
60. Ribosomes 6%
61. Renal Cell Carcinoma 6%
62. Intellectual Disability 6%
63. Genome 6%
64. Glucocorticoids 5%
65. Protein-Tyrosine Kinases 5%
66. Phosphotransferases 5%
67. DNA Mismatch Repair 5%
68. Amino Acids 5%
69. Patient Selection 5%
70. 5' Untranslated Regions 5%
71. Bone Marrow 5%
72. Squamous Cell Carcinoma 5%
73. Short Interspersed Nucleotide Elements 5%
74. Immunity 5%
75. T-Cell Antigen Receptor 5%